Kenneth D Hochstetler
@Everence Capital Management Inc
Latest period2024 - Q4ReportedManaged Assets$1.539BTotal holdings814
Assets growth rate-2.88%Assets growth rate (2-Q avg)3.49%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Everence Capital Management Inc's 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 814 positions.
Assets under management
The assets under management (AUM) of Everence Capital Management Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 1.539B in assets, with a quarterly growth rate of -2.88% and a 2-quarter average growth rate of 3.49%. The portfolio is managed by Kenneth D Hochstetler, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
YELPYelp Inc
| 0% | $402,000 11,460 shares@ $35.08 avg price | Exited |
BLFSBiolife Solutions Inc
| 0% | $395,000 15,770 shares@ $25.05 avg price | Exited |
LNNLindsay Corp
| 0% | $391,000 3,140 shares@ $124.53 avg price | Exited |
HOLXHologic Inc
| 0% | $389,000 4,780 shares@ $81.39 avg price | Exited |
QDELQuidelortho Corp
| 0% | $388,000 8,500 shares@ $45.65 avg price | Exited |
ENVEnvestnet Inc
| 0% | $388,000 6,190 shares@ $62.69 avg price | Exited |
VMCVulcan Materials
| 0% | $381,000 1,520 shares@ $250.66 avg price | Exited |
TGTXTg Therapeutics
| 0% | $380,000 16,260 shares@ $23.38 avg price | Exited |
SITCSite Ctrs Corp Com
| 0% | $380,000 6,285 shares@ $60.47 avg price | Exited |
COLLCollegium Pharmaceutical
| 0% | $379,000 9,800 shares@ $38.68 avg price | Exited |